Hospital
Freeman Neosho Hospital
Freeman Neosho Hospital was paid $6.06M by Medicaid between Jan 2018 and Nov 2024, across 51 billing codes. Its largest line is X4011, State-specific procedure code — 30% of everything it billed.
33Billing provider infoFREEMAN NEOSHO HOSPITAL
NEOSHO, MO 64850
NEOSHO, MO 64850
33aNPI1598873796assigned 08/28/2006
33bProvider typeCritical Access Hospital
28Total paid$6.06M
24GClaims54,224
24DCodes billed51
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Missouri
Rank by total paid#10 of 33
Median peer was paid$2.24M
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,829 | $1.39M | |
| 2019 | 6,154 | $1.09M | |
| 2020 | 3,652 | $492K | |
| 2021 | 6,392 | $231K | |
| 2022 | 9,115 | $734K | |
| 2023 | 12,333 | $1.19M | |
| 2024incomplete | 7,749 | $934K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| X4011 | State-specific procedure code | 30% | 7,215 | 7,017 | $1.80M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 6,750 | 6,519 | $1.22M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 3,488 | 3,276 | $882K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.1% | 1,100 | 999 | $372K |
| 80053 | Comprehensive metabolic panel | 5.7% | 6,382 | 5,965 | $344K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.5% | 7,395 | 6,832 | $333K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.3% | 2,277 | 2,244 | $263K |
| 81001 | 3.7% | 4,207 | 3,982 | $226K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.2% | 1,301 | 1,258 | $196K |
| 87400 | 1.4% | 481 | 451 | $88K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.1% | 1,314 | 1,243 | $64K |
| J3490 | Unclassified drugs | <1% | 3,400 | 2,945 | $50K |
39 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 383 | $33K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 307 | $28K |
| 71045 | Radiologic examination, chest; single view | <1% | 337 | $21K |
| 87081 | <1% | 210 | $20K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 738 | $14K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 237 | $13K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 117 | $12K |
| 83655 | <1% | 1,009 | $10K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 138 | $10K |
| 84484 | <1% | 620 | $7K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 275 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 117 | $6K |
| 82550 | <1% | 645 | $4K | |
| 82553 | <1% | 404 | $4K | |
| 87420 | <1% | 27 | $4K | |
| 84703 | <1% | 315 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 50 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 341 | $3K |
| 83690 | <1% | 508 | $3K | |
| 87428 | <1% | 88 | $2K | |
| 80061 | Lipid panel | <1% | 246 | $2K |
| 84145 | <1% | 105 | $2K | |
| 81002 | <1% | 484 | $2K | |
| 83605 | <1% | 180 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 17 | $1K |
| 85018 | <1% | 247 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 155 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $987.04 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 137 | $900.00 |
| 80306 | <1% | 48 | $727.85 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 37 | $282.98 |
| 36415 | Collection of venous blood by venipuncture | <1% | 27 | $232.50 |
| 85730 | <1% | 37 | $152.62 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 197 | $144.15 |
| 85610 | <1% | 37 | $108.96 | |
| 81003 | <1% | 12 | $26.94 | |
| 85027 | <1% | 29 | $13.32 | |
| 84439 | <1% | 12 | $11.37 | |
| 85007 | <1% | 29 | $7.83 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGRADDY, STEVE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Freeman-Oak Hill Health System | Joplin, MO | $14.73M |
| Freeman-Oak Hill Health System | Anderson, MO | $1.01M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.